To learn more about the book this website supports, please visit its Information Center. 2006 McGraw-Hill Higher Education Any use is subject to the Terms of.

Gastric Cancer: Practice Essentials, Background, Anatomy. World Health Organization. Cancer: Fact Sheet No 2. Available at http: //www.

Accessed: May 2. 1, 2. Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Stomach Cancer. National Cancer Institute.

Available at http: //seer. Accessed: May 2. 1, 2. Avital I, Pisters PWT, Kelsen DP, Willett CG. Cancer of the Stomach. De. Vita VT, Lawrence TS, Rosenberg SA.

De. Vita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer.

Version 3. 2. 01. Available at http: //www. Accessed: August 9, 2. Global Cancer Facts & Figures, 3rd ed. American Cancer Society. Available at http: //www.

• The human heart is an organ that pumps blood throughout the body via the circulatory system.
• It is a muscular, highly vascular bag-shaped organ that is.
• Description: The ultimate anatomy atlas for clinical reference, patient education and personal study is now even better. The standard by which all others are measured.
• Endoscopic retrograde cholangio-pancreatography is a procedure that uses a small scope to examine the stomach and intestines. The patient should not eat anything.
• John runs a health communications and consulting firm. She is also an author and editor, and was formerly a senior medical officer with the U.S.
• Viral gastroenteritis (viral infection of the stomach and the small intestine) is the most common cause of acute diarrhea worldwide. Symptoms of viral gastroenteritis.

Assessment Tools: Introduction to the Anatomy and Physiology of the Auditory System. By: Sarah E. Ervin, M.A., CCC-A. The human brain is the command center for the human nervous system. A project to map the structure and function of the human brain has been proposed.

STT/Global. Accessed: May 2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 3. 45(1.

Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 3. 55(1): 1. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. Jul 2. 7. What are the key statistics about stomach cancer?

American Cancer Society. Available at http: //www. Megui Encoding Tools For The Pro there. February 1. 0, 2. Accessed: January 4, 2.

Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re- operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.

Int J Radiat Oncol Biol Phys. Diet modification and gastric cancer prevention. J Natl Cancer Inst Monogr. Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, et al.

A case- control study of gastric cancer and diet in Italy. Int J Cancer. 1. 98. Oct 1. 5. 4. 4(4): 6. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA.

Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer. 2. 00. Nov 2. 0. 1. 07(4): 6. Wu X, Zeng Z, Chen B, Yu J, Xue L, Hao Y, et al.

Association between polymorphisms in interleukin- 1. A and interleukin- 1. F genes and risks of gastric cancer. Int J Cancer. 2. 00.

Nov 1. 0. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosom. Vol 6. 1 of IARC monographs on the evaluation of carcinogenic risks to humans.

International Agency for Research on Cancer, Lyon, 1. J Clin Oncol. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol. 2. 3(3): 2. Guilford P, Hopkins J, Harraway J, et al.

E- cadherin germline mutations in familial gastric cancer. Cardwell CR, Abnet CC, Cantwell MM, Murray LJ.

Exposure to oral bisphosphonates and risk of esophageal cancer. Aug 1. 1. 3. 04(6): 6. Usefulness of dual- time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancer. Cancer Biother Radiopharm. A new gastric cancer subtype responds to 5- FU. Medscape Medical News. September 4, 2. 01.

Identification of molecular subtypes of gastric cancer with different responses to PI3- kinase inhibitors and 5- fluorouracil. Gastroenterology. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer; 2.

Najam AA, Yao JC, Lenzi R, et al. Linitis plastica is common in women and in poorly differentiated and signet ring cell histologies: an analysis of 2. Proc Am Soc Clin Oncol. Shen KH, Wu CW, Lo SS, et al. Factors correlated with number of metastatic lymph nodes in gastric cancer. Am J Gastroenterol.

Lee SE, Ryu KW, Nam BH, Lee JH, Choi IJ, Kook MC, et al. Prognostic significance of intraoperatively estimated surgical stage in curatively resected gastric cancer patients. J Am Coll Surg. 2. Ozcan S, Barkauskas DA, Ruhaak LR, Javier Torres J, Cooke CL, An H, et al. Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila).

Dec 1. 0. Researchers Discover 'Glycan Fingerprint' for Gastric Cancer. Available at http: //www. Accessed: January 1. Gastric cancer: ESMO- ESSO- ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow- up. Suppl 6: vi. 57- 6. Subtotal versus total gastrectomy for gastric cancer: five- year survival rates in a multicenter randomized Italian trial.

Italian Gastrointestinal Tumor Study Group. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al. Extended lymph node dissection for gastric cancer. N Engl J Med. 1. 99. Mar 2. 5. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit?

Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2. 2(1. Degiuli M, Sasako M, Ponti A. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Memon MA, Subramanya MS, Khan S, et al.

Meta- analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Sindelar WG, Kinsella TJ. Randomized trial of resection and intraoperative radiotherapy in locally advanced gastric cancer. Proc Ann Meet Am Soc Clin Oncol. Moertel CG, Childs DS, Reitemeier RJ, et al. Combined 5- fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Oct 2. 5. 2(7. 62.

Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five- year follow- up. May 2. 8. 3. 43(8. Gastrointestinal Tumor Study Group. The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group.

Moertel CG, Childs DS, O'Fallon JR, et al. Combined 5- fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol. 2(1. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated Analysis of SWOG- Directed Intergroup Study 0.

A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection. J Clin Oncol. 3. 0(1. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non- Asian patients: revisiting a meta- analysis of randomised trials. Eur J Cancer. 3. 5(7): 1. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open- label, randomised controlled trial.

Jan 2. 8. 3. 79(9. Narahara H, Koizumi T, Hara A, et al. Randomized phase III study of S- 1 alone versus S- 1+cisplatin in the treatment for advanced gastric cancer. J Clin Oncol. US Food and Drug Administration.

FDA approves Cyramza for stomach cancer . April 2. 1, 2. 01.

Available at http: //www. News. Events/Newsroom/Press. Announcements/ucm. Accessed: April 2. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ.

Gastric cancer. 3. Kim HK, Choi IJ, Kim CG, Oshima A, Green JE.

Gene expression signatures to predict the response of gastric cancer to cisplatin and fluorouracil. J Clin Oncol. Evaluation of prognostic factors for the response to S- 1 in patients with stage II or III advanced gastric cancer who underwent gastrectomy. Pharmacogenet Genomics. Van Cutsem E, Kang Y, Chung H, Shen L, Sawaki A, Lordick F, et al. Efficacy results from the To. GA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first- line human epidermal growth factor receptor 2 (HER2)- positive advanced gastric cancer (GC). American Society of Clinical Oncology.

Available at http: //meeting. S/LBA4. 50. 9. Accessed: November 2.